Article

Cancer Treatment Advances Highlight Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/cancer-treatment-advances-highlight-specialty-phar" target="_blank">View the story "Cancer Treatment Advances Highlight Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Image Credit: © Krakenimages.com - stock.adobe.com
Image Credit: © Cavan - stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Image Credit: © RandyJay - stock.adobe.com
WCLC, lung cancer, NSCLC
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC
Related Content
FDA, Tirzepatide, Drug Shortage, Compounding Pharmacy | Image Credit: tyyang - stock.adobe.com
October 23rd 2024

FDA To Reevaluate Removal of Tirzepatide From Drug Shortage List

Ashley Gallagher, Associate Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Image Credit: © Kevin Ruck - stock.adobe.com
October 23rd 2024

Key Sessions and Expert Interviews at the NCODA Fall Summit

Alexandra Gerlach, Associate Editor
Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings
August 29th 2024

Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

Image Credit: © Africa Studio - stock.adobe.com
October 22nd 2024

Patients With Endometriosis Have an Increased Risk of Developing Cardiovascular Disease

Alexandra Gerlach, Associate Editor
Cancer cells, 3D illustration
October 22nd 2024

Mycosis Fungoides and Sézary Syndrome, Subtypes of Cutaneous T-Cell Lymphoma, Compromise Health-Related Quality of Life in Patients

Luke Halpern, Assistant Editor